One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The death of a Quebec teen who was poisoned from a synthetic opioid should raise alarm bells for authorities to do more to ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The unprecedented increase in drug overdose deaths in the United States, long believed to be driven by access to legal and ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

The decision is aimed at boosting cash flow and reducing debt as it faces an opioid lawsuit from the Department of Justice.

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him of “misconduct or inappropriate behavior.” ...